T1	Intervention 3 132	allopurinol-controlled, randomized, double-dummy, double-blind, parallel between-group, comparative study of febuxostat (TMX-67),
T2	Intervention 254 276	phase 3 clinical study
T3	Intervention 488 513	Febuxostat or allopurinol
T4	Intervention 648 840	Doses of febuxostat and allopurinol were 10 and 100 mg/d, respectively, during a 12-day introduction period and were increased to 40 and 200 mg/d for the subsequent treatment period of 44 days
